2m 2m 2m 2m 2m 2m 2m
DYNE THERAPEUTCS (DYN)
NASDAQ
$18.06-$0.15 (-0.82%)
Price as of Sep 11, 2026 7:30 PM EDT- $3.4BMarket Cap
- 38.48%1-Year Change
- BiotechnologyIndustry
DYNE THERAPEUTCS (DYN)
$18.06-$0.15 (-0.82%)
DYN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.21 | ||
Change | -$0.21 (-1.14%) | ||
Open | $18.59 | ||
High | $18.74 | ||
Low | $17.94 | ||
Previous Close | $18.42 | ||
Volume | 3,774,440 | ||
30-Day Average Volume | 2,735,612 | ||
1-Week Change | -25.00% | ||
1-Month Change | -31.82% | ||
1-Year Change | 38.48% | ||
3-Year Change | 62.88% | ||
5-Year Change | 14.17% | ||
Fundamentals | |||
Shares Outstanding | 186.7M | ||
Total Assets | $994.0M | ||
Market Cap | $3.4B | ||
Enterprise Value | $2.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$178.6M | ||
Free Cash Flow | -$131.8M | ||
EBIT | -$174.0M | ||
EBITDA | -$173.4M | ||
Net Working Capital | $859.9M | ||
EPS | -$1.08 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue